Mergers & Acquisitions - Pharmaceutical, Neurological


Popular Filters

1 to 25 of 50 results

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options


UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer


After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie


Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Kyowa Hakko to acquire Archimedes for £230 million

Kyowa Hakko to acquire Archimedes for £230 million


Through its Scotland-based subsidiary ProStrakan Group, Japanese drugmaker Kyowa Hakko Kirin has entered…

ArchimedesArchimedes PharmaBusiness FinanceDriverHealth Medical PharmaKyowa Hakko KirinMergers & AcquisitionsNeurologicalNovo A/SOncologyPharmaceuticalPharmaceutical industryProStrakanUK

Lundbeck to complete Chelsea Thera acquisition today

Lundbeck to complete Chelsea Thera acquisition today


Danish CNS specialist Lundbeck says that it has completed the tender offer to buy all of the outstanding…

Chelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNortheraPharmaceutical

Roche partners in new company for MS research

Roche partners in new company for MS research


Swiss drug major Roche has entered into an exclusive partnership with Inception Sciences, a drug discovery…

Inception 5Inception SciencesMergers & AcquisitionsNeurologicalPharmaceuticalResearchRocheVersant Ventures

Cipla invests $1.5 million for 14.6% stake in USA’s Chase Pharma


Indian drugmaker Cipla has said it will acquire a 14.6% stake in US-based Chase Pharmaceuticals for $1.5…

Chase PharmaceuticalsCiplaCPC 201Mergers & AcquisitionsNeurologicalPharmaceutical

Perrigo transfers ELND005 assets; buys OTC products


Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer


Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

NuPathe rockets on news of takeover by Endo Health

NuPathe rockets on news of takeover by Endo Health


In a third take-over deal announced this year, USA-based specialty health care company Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalZecuity

Torrent to acquire Indian branded formulations from Elder


Torrent Pharmaceuticals saw its shares rise 7% to 349 rupees after it said it is acquiring the branded…

Asia-PacificElder PharmaceuticalsIndiaMergers & AcquisitionsNeurologicalPharmaceuticalTorrent PharmaceuticalsWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon


In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Sorrento Therapeutics gets clinical-stage chronic pain drug, along with Sherrington acquisition


Sorrento Therapeutics has acquired Sherrington Pharmaceuticals. Financial terms of the deal were not…

CynviloqMergers & AcquisitionsNeurologicalPharmaceuticalresiniferatoxinSherrington PharmaceuticalsSorrento Therapeutics

Ipsen makes acquisition and signs R&D deal with Harvard


French drugmaker Ipsen (Euronext: IPN) has acquired UK life sciences company Syntaxin for an upfront…

EuropeIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSyntaxin

Biotie buys option to acquire Neurelis, and opportunity for epilepsy candidate


Finland-based biotech firm Biotie Therapies (Nasdaq-OMX; BTH1V) says that it has obtained an exclusive…

BiotechnologyBiotie TherapiesMergers & AcquisitionsNeurelisNeurologicalNRL-1Pharmaceutical

Phytopharm views options, including merger, as Cogane fails


UK-based Phytopharm (LSE: PYM: London Stock Exchange), ahead of its annual general meeting today (March…

CoganeMergers & AcquisitionsNeurologicalPharmaceuticalPhytopharmResearch

Elan sells its Tysabri rights to Biogen; posts 2012 financials


Ireland-based drugmaker Elan Corp (NYSE: ELN) said yesterday that partner US biotech firm Biogen Idec…

Biogen IdecBiotechnologyElanFinancialMergers & AcquisitionsNeurologicalPharmaceuticalTysabri

Allergan to acquire MAP Pharmaceuticals in $958 million deal


US drugmaker Allergan (NYSE: AGN) has entered into a definitive merger agreement to acquire 100% of the…

AllerganLevadexMAP PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceutical

Watson acquires Uteron Pharma; confirms Opana patent challenge


US generic and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) says that it has completed the…

Endo PharmaceuticalsGenericsGrunenthalMergers & AcquisitionsNeurologicalNorth AmericaOpanaPatentsPharmaceuticalUteron PharmaWatson PharmaceuticalsWomen's Health

BioMarin acquires Zacharon Pharma for upfront $10 million


US drugmaker BioMarin Pharmaceutical (Nasdaq: BMRN) says it has acquired Zacharon Pharmaceuticals, a…

BioMarin PharmaceuticalMergers & AcquisitionsNeurologicalPharmaceuticalZacharon Pharmaceutical

Illumina to buy Verinata; Rusnano et al invest in Marinus


USA-based Illumina (Nasdaq: ILMN), recently the subject of a failed takeover bid by Swiss drug major…

Domain AssociatesFinancialganaxoloneIlluminaMarinus PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalResearchRusNanoVerinata Health

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex


Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

1 to 25 of 50 results

Back to top